Table 2. Circulating adipocytokines and hsCRP levels of the subjects.
| Control group (n = 25) |
High HFF group (n = 16) |
|
|---|---|---|
| Adiponectin (μg mL−1) | 20.8 ± 2.3 | 18.1 ± 3.0 |
| PAI-1 (ng mL−1) | 133.5 ± 12.3 | 130.2 ± 23.4 |
| Resistin (ng mL−1) | 52.4 ± 6.0 | 38.3 ± 7.0 |
| IL-8 (pg mL−1) | 3.2 ± 0.4 | 6.1 ± 1.6* |
| Leptin (ng mL−1) | 41.6 ± 6.5 | 41.4 ± 4.9 |
| TNF-alpha (pg mL−1) | 11.4 ± 1.4 | 15.4 ± 2.4 |
| MCP-1 (pg mL−1) | 259.7 ± 21.2 | 279.0 ± 39.1 |
| HGF (ng mL−1) | 1.2 ± 0.1 | 1.4 ± 0.3 |
| NGF (pg mL−1) | 13.9 ± 1.6 | 30.2 ± 9.9* |
| hsCRP (mg L−1) | 4.0 ± 1.9 | 3.6 ± 1.1 |
Data expressed as mean ± SE. Independent t-tests were used to test for differences between groups.
*
P < 0.05.
HGF, hepatocyte growth factor; hsCRP, high sensivity C-reactive protein; IL-8, interleukin-8; MCP-1, monocyte chemoat-tractant protein-1; NGF, nerve growth factor; PAI-1, plasminogen activator inhibitor-1; TNF-alpha, tumour necrosis factor-alpha.